KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Total Non-Current Liabilities (2016 - 2025)

Resmed's Total Non-Current Liabilities history spans 16 years, with the latest figure at $934.4 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 9.84% year-over-year to $934.4 million; the TTM value through Dec 2025 reached $934.4 million, down 9.84%, while the annual FY2025 figure was $1.2 billion, 8.17% up from the prior year.
  • Total Non-Current Liabilities reached $934.4 million in Q4 2025 per RMD's latest filing, roughly flat from $931.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.2 billion in Q4 2022 to a low of $930.7 million in Q2 2021.
  • Average Total Non-Current Liabilities over 5 years is $1.3 billion, with a median of $1.1 billion recorded in 2021.
  • Peak YoY movement for Total Non-Current Liabilities: tumbled 41.27% in 2021, then skyrocketed 127.85% in 2022.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $967.8 million in 2021, then skyrocketed by 127.85% to $2.2 billion in 2022, then fell by 24.76% to $1.7 billion in 2023, then plummeted by 37.54% to $1.0 billion in 2024, then fell by 9.84% to $934.4 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Total Non-Current Liabilities are $934.4 million (Q4 2025), $931.6 million (Q3 2025), and $1.2 billion (Q2 2025).